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The intake, as well as serum and urinary concentrations, of phytoestrogens is high in countries where incidence of prostate cancer is low,
suggesting a chemopreventive role for phytoestrogens. Their significance could be explained by the ability to antagonize the action of more potent
endogenous estrogens in initiation or promotion of tumor formation. We have studied estrogenicity and antiestrogenicity of dietary soy and two
phytoestrogens, coumestrol and daidzein, in our neoDES mouse model for the study of prostatic neoplasia. Soy was chosen because it is rich in
phytoestrogens, is widely used in Oriental diets, and has antiestrogenic and anticarcinogenic properties in the neoDES mouse when given from
fertilization onward. In short-term tests with adult animals, no evidence for estrogenicity or antiestrogenicity (capability to antagonize the action of
17,B-estradiol) of soy was found when development of epithelial metaplasia and expression of c-fos protooncogene in prostate were used as end
points of estrogen action. Estrogenic activity of coumestrol and daidzein on c-fos expression was subtle. Coumestrol, either given alone or in combi-
nation with 17,B-estradiol, had no effect on development of epithelial metaplasia. These marginal or missing effects in adult males could be inter-
preted by assuming that the neonatal period is more critical for estrogenic or antiestrogenic action of soy and phytoestrogens. Once initiated,
estrogen-related lesions would develop spontaneously. Alternatively, the chemopreventive action of soy is not due to antiestrogenicity of soy-
derived phytoestrogens. - Environ Health Perspect 103(Suppl 7):123-127 (1995)
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Introduction
Dietary soy has chemopreventive proper-
ties in several animal models for cancers
(1-3). There is also suggestive evidence
that dietary soy (tofu) is chemopreventive
in human prostate cancer (4). Using the
developmentally estrogenized mouse model
(5,6), we have shown that the estrogen-
related inhibition of prostatic growth is
reduced and the development ofdysplastic
changes is delayed in the prostate when the
animals are kept on soy-containing feed
from fertilization onward (7). Both the
number of animals showing dysplasia and
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also the severity ofthe alterations in dysplas-
tic epithelium were lower in animals given
soy. Morphologically the dysplastic lesions
in the prostate ofneoDES animals are simi-
lar to prostatic intraepithelial neoplasia
(PIN) in human prostate (8). Although no
progression to carcinomas with invasion of
surrounding tissues or metastasis could be
demonstrated, the morphological changes
and increased expression of protoonco-
genes in developmentally estrogenized mice
suggest an increased potential for benign
and malignant growth (Table 1).
Soy is rich in phytoestrogens, weakly
estrogenic nonsteroidal compounds. Their
urinary excretion (particularly that of
isoflavones) correlates with the ingestion
of soy in our animal experiments (7). In
humans, urinary excretion and serum
concentrations of phytoestrogens are
higher in countries where the incidence of
prostate cancer is low (9,10). This sug-
gests that phytoestrogens may account for
the chemopreventive action of soy in
prostate carcinogenesis.
The mechanisms of the possible
chemopreventive action of phytoestrogens
are not known. Their significance could be
explained by their ability to antagonize
the action of more potent endogenous
estrogens in initiation or promotion of
carcinogenesis, although currently no
direct evidence for this action is available.
The mouse model based on neonatal
diethylstilbestrol treatment (neoDES
model) is particularly suitable for testing
this hypothesis. In neoDES mice the histo-
logical response to 17p-estradiol in terms
of metaplastic transformation and the
17p-estradiol-induced expression of c-fos
protooncogene are greatly enhanced. Based
on these end points ofestrogen action, we
have tested the estrogenicity and antiestro-
genicity ofdietary soy and two structurally
different phytoestrogens, coumestrol and
daidzein, both known to be present in soy.
Materials and Methods
Animals andDiets
Outbred Han-NMRI mice (produced by
the Animal Quarters, Institute of
Biomedicine, University ofTurku, Turku,
Finland) were used throughout the study.
The test protocols were approved by the
Turku University Committee on the
Laboratory Animal Center. The animals
were given free access to feed and tap
water. A soyfree diet, where soy is substi-
tuted with casein, was purchased from
Finnewos (Helsinki, Finland) and Special
Diet Services, (Witham, Essex, United
Kingdom). A standard soy-containing lab-
oratory feed for mice (Ewos R3) contain-
ing cereals, wheat germ, wheat middlings,
roasted soy meal (7%), fish protein con-
centrate, fodder yeast, minerals, animal
and vegetable fat, vitamin concentrate,
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Table 1. Effects of neonatal estrogenization in mouse urethroprostatic complex (2 pg of diethylstilbestrol per day
on days 1 to 3 after birth).
Prostatic growth Permanent growth inhibition of all lobes (5)
Tissue composition Increase in the relative volume of prostatic interacinar stroma (5)
Increased amount of periurethral glands (5)
Epithelial structure Hyperplasia and dysplasia in posterior periurethral region and collecting ducts
(sites adjacentto estrogen receptor-positive stroma)(6)
Expression of estrogen- Permanent increase in c-mycand c-fosexpression [(6); S Makel3, unpublished
responsive protooncogenes results]
Response to secondary Enhanced estrogen sensitivity (estimated bythe development of epithelial
estrogen treatment metaplasia in collecting ducts and expression ofc-fosoncogene after
treatment with 17p-estradiol) [(6); S Makela, unpublished results]
Voiding function Altered voiding pattern (increased voiding frequency, decreased voiding volumes)
(S Makela, unpublished results)
Decreased ratio ofurinaryflowto bladderpressure (S Makela, unpublished results)
Immune system Inflammatory changes(5)
and trace element concentrate was pre-
pared by Finnewos, Helsinki, Finland.
The animals were kept on soyfree diet, and
the soy-containing diet was used only in
the experiments.
Neonatal Estrogenizationwith
Diethyistilbestrol (neoDESTreatnent)
Male pups were injected sc with 2 pg of
diethylstilbestrol (DES) in 20 pl ofcorn oil
per day for the first 3 days after birth.
Induction ofMetaplastic Reaction
Adult neoDES mice (3-5 months of age)
were castrated under barbiturate anesthesia.
In soy experiments the animals were
divided into four groups: group 1 contin-
ued on the soyfree diet; group 2 was trans-
ferred to the soy-containing diet; group 3
received an sc implant with 50 pg estradiol
and continued on the soyfree diet; and
group 4 received an sc implant with 50 pg
estradiol and was transferred to the soy-
containing diet. In experiments with
coumestrol, the animals were divided into
four groups: group 1 received the vehicle,
20 pl of dimethyl sulfoxide (DMSO) per
day sc; group 2 received 25 pg ofestradiol
in DMSO sc per day; group 3 received 50
pg ofcoumestrol in DMSO sc per day; and
group 4 received both estradiol and
coumestrol. After 10 days (soy experiment)
and 7 days (coumestrol experiment) the
animals were sacrificed; the urethroprosta-
tic blocks were removed and used for histo-
logic preparations. Tissue blocks were fixed
whole in Bouin's fixative, dehydrated, and
embedded in paraffin. Serial horizontal
6-pm sections with 200-pm intervals were
cut through the tissue block, from lower
urethra up to the upper halfofthe urinary
bladder. The sections were stained with
routine hematoxylin and eosin, dehy-
drated, and mounted with Permount. The
sections were carefully studied for the pres-
ence of squamous epithelial metaplasia in
the periurethral collecting ducts and proxi-
mal parts ofcoagulating gland, dorsolateral
prostate, and seminal vesicles.
Induction ofc-bsExpression
Adult (3-5 months of age) neoDES mice
were castrated under barbiturate anesthesia
and, after 7 days, theywere injected sc with
17,B-estradiol (100 pg/animal), coumestrol
(200 pg/animal), or daidzein (200 pg/ani-
mal) diluted in corn oil (100 pl/animal).
The controls received the vehicle only. In
the soy experiment, the animals were kept
on the soy diet from castration onward.
Animals were sacrificed 3, 6, or 12 hr after
injection and urethroprostatic blocks were
removed. Tissues were transferred to a
petri dish containing phosphate-buffered
saline (PBS) and prostatic lobes, seminal
vesicles, and prostatic urethra were dis-
sected under a microscope. Tissue samples
were immediately frozen in liquid nitrogen
and stored at -70°C. Total RNAs were
extracted with the single step method (11).
Fifteen-microgram aliquots of total RNA
were size-fractionated in 1% agarose/for-
maldehyde gels and blotted onto nylon
membrane (GeneScreen, DuPont, NEN,
Boston, MA). The filters were hybridized
and washed as suggested by the manufac-
turer. The 32P-labeled c-fos antisense RNA
probe was synthesized from the insert in a
pGEM vector (Promega, Madison, WI)
according to the manufacturers directions,
using Sp6 RNA polymerase; the radiola-
beled probe was added directly to the pre-
hybridization mixture. The c-fos probe was
kindly provided by George Stancel
(University of Texas, Houston TX). This
mouse c-fos probe was originally obtained
by digestion and subcloning of mouse pc-
fos-3 (12). For quantitation, the signal
intensities of autoradiographic films were
scanned with the Microcomputer Imaging
Device (MCID) by using M4, version 2.1
software program (Imaging Research Inc.,
Ontario, Canada). The intensity values of
c-fos were corrected by the corresponding
intensity values obtained after hybridiza-
tion with mouse 28S ribosomal RNA
probe. The 4.8 kb SalI-EcoRI fragment of
mouse 28S ribosomal RNA cDNA was
32P-dCTP labeled by random priming.
Resufts
Effects ofDietarySoyandCoumestrol
onDevelopmentofSquamous
EpithelialMetaplasia
An extensive squamous metaplasia was
observed in the periurethral collecting
ducts, as well as in the periurethral parts of
coagulating glands, when castrated
neoDES animals fed a soy-free diet were
treated with estrogen pellets (50 pg of17p-
estradiol per pellet) for 10 days or with
daily injections (25 pg of17p-estradiol per
day) for 7 days (Figure 1A,B)
When adult neoDES animals were kept
on a soy-containing diet for 10 or 21 days
after castration, no signs of squamous
epithelial metaplasia could be observed.
Soy feeding did not prevent the metaplastic
reaction induced by 173-estradiol implants
(Figure 1C,D).
Coumestrol (50 pg per day for 7 days
given sc) did not induce squamous meta-
plasia in neoDES animals. Neither did it
inhibit the metaplastic reaction induced by
171B-estradiol injections (Figure 1E,F).
Thus, based on squamous epithelial meta-
plasia, there is no evidence that either
coumestrol or dietary soy are estrogenic or
antiestrogenic.
Inductionofc-JbsExpression
17J-Estradiol induced the expression ofc-
fos in neoDES mice given a soy-free diet.
After the sc injection of 170-estradiol
(100 pg/animal) the increased expression
was evident in the prostatic urethra and
coagulating glands at 3 to 12 hr after
injection (Figure 2).
Soy given to neoDES animals for 1
week before 17,B-estradiol injection had no
effect on the expression. Further, coume-
strol and daidzein in a dose of200 pg/ani-
mal sc showed weak estrogenic action
(Figure 2), but there is no evidence that
soy acts as an antiestrogen based on the
induction ofc-fos expression.
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Figure 1. Microscopic structure of prostatic collecting ducts in the posterior periurethral region of an adult cas-
trated neoDES mouse kept on soyfree diet. (A) treated with an sc implant containing 50 pg estradiol and kept on
soyfree diet for 7 days; (B) given a soy-containing diet for 10 days postcastration; (C) treated with an sc implant
with 50 pg estradiol and kept on a soy-containing diet for 10 days postcastration; (D) treated with 50 pg coume-
strol in DMSO sc per day for 7 days postcastration; (E) treated sc with 25 pg estradiol; and (F) 50 pg coumestrol in
DMSO for 7 days postcastration.
Discussion
Despite the greater estrogen sensitivity, no
evidence for the estrogenicity ofdietary soy
(diet with 7% of roasted soy meal) was
found in the prostate ofneonatally estroge-
nized, adult castrated male mice when
judged on the basis of development of
squamous epithelial metaplasia. The lack of
the estrogenicity of soy is in contrast to the
findings in the immature female mouse in
which the estrogenicity of diet with 7% of
roasted soy meal was confirmed by the uter-
ine growth response (7). The estrogenlike
effect by dietary soy was also demonstrable
on the prostatic growth in the male rat
when exposed to dietary soy from fertiliza-
tion onward: the size ofthe ventral prostate
was reduced at 2 months ofage (13). In the
corresponding feeding experiment with the
male mouse, the sizes of the sex accessory
glands were reduced but the differences
were not statistically significant (7).
Coumestrol, one of the most potent
phytoestrogens, was also incapable of
inducing metaplastic transformation in
neonatally estrogenized mice; as docu-
mented earlier, it did not inhibit the pro-
static growth when administered to normal
adult rats (13). However, when the induc-
tion of the expression of estrogen-respon-
sive gene, c-fos (one ofthe immediate early
genes in mitosis) in adult neoDES mice
was used as an end point, both coumestrol
and daidzein showed weak estrogenlike
activity. Also in rat uterus the antiestrogen
tamoxifen was shown to induce a weak
response in c-fos expression (14). This
weak estrogenlike (or antiestrogenlike)
effect is induced by phytoestrogen doses
comparable to the amounts ingested by
Figure 2. Effects of 171-estradiol, coumestrol,
daidzein, and soy diet on c-fos in the prostatic urethra
and coagulating gland of castrated neoDES male mice.
Abbreviations: Oil, vehicle only; E2, 17f-estradiol (100
pg sc); Cou, coumestrol (200 pg sc); Dai, daidzein (200
pg sc). (A) Effect of 17)3-estradiol, coumestrol, daidzein
on the expression of c-fos in the prostatic urethra of
castrated neoDES mice. The bars show the combined
data from all experiments. Values are expressed as per-
centages of expression after 3-hr E2-treatment (using
the corrected scanning units of c-fos relative to 28S).
Each bar represents the expression in three to nine ani-
mals. (B) A representative Northern blot from one
experiment. Lane 1-vehicle only (oil), 3 hr; lane 2-E2,
3 hr; lane 3-E2, 6 hr; lane 4-E2, 12 hr; lane 5-coume-
strol, 3 hr; lane 6-coumestrol, 6 hr; lane 7-coumestrol,
12 hr; lane 8-daidzein, 3 hr; lane 9-daidzein, 6 hr; lane
10-daidzein, 12 hr. Each sample consists of mRNAfrom
three animals. (C) Effect of dietary soy on the estradiol-
induced expression of c-fos in the coagulating gland of
castrated neoDES mice. Lane 1, soyfree diet from cas-
tration onward plus treatment with vehicle only; lane 2,
soyfree diet from castration onward plus treatmentwith
17p3-estradiol (100 pg sc); lane 3, soy diet from castra-
tion onward plus treatment with 17j3-estradiol (100 pg
sc). Injections were given on day7 postcastration and all
samples were taken 3 hr after injection. Corresponding
ethidium bromide (E+Br)staining is shown belowc-fos.
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laboratory rodents in daily soy-based feed
(15) and may therefore be of significance
for the effects associated with the high
intake ofdietary soy.
The weak estrogenicity of coumestrol
seen in the adult male is again contradic-
tory with the findings in female rodents. It
is very well documented that coumestrol is
a potent estrogen in the developing female
reproductive tract. It had DES-like effects
in the neonatal female mouse (16) and
promoted uterine growth in immature rats
when given in doses (per body weight)
similar to those we used (15,17-19). In
adult ovariectomized rats, coumestrol
showed partial estrogen agonism; it was
uterotrophic but did not induce ovum
implantation in mated, ovariectomized
gestagen-maintained animals (20). The
conflicting findings on the hormonal
potency ofsoy or coumestrol cannot yet be
explained, but they could be due to sex- or
age-related differences in the uptake or
metabolism ofphytoestrogens.
It is also intriguing that in adult male
mice soy did not block the estrogen-
induced metaplastic transformation or
expression of c-fos protooncogene, and
coumestrol did not inhibit the development
of metaplasia in 17p-estradiol-treated ani-
mals. This is in conflict with the idea ofthe
antiestrogenicity ofsoy seen as reduction of
the growth inhibition of the prostate and
prevention of dysplastic development after
neonatal estrogenization and the reduction
of the estrogen-induced growth of imma-
ture uterus (7). One could interpret these
findings by assuming that in males the
neonatal or prepubertal period would be
more critical for estrogen and antiestrogen
actions. Once initiated, the estrogen-related
lesions would develop spontaneously.
It is not easily concievable how soy or
phytoestrogens could antagonize the estro-
gen action at the target cells. Phytoestrogens
(coumestrol, daidzein, genistein) are clearly
estrogen agonists in breast cancer cells in
vitro and act through the estrogen receptor
(ER)-mediated mechanisms (21,22).
Phytoestrogens with high binding affinities
for estrogen receptor are also most active
biologically (e.g., they enhance cell prolif-
eration) (23). Phytoestrogens are supposed
to act as antiestrogens by competing with
more potent endogenous estrogens for the
binding to ER. Dietary estrogens repre-
senting three structurally different groups
(coumestans, isoflavonoids, and resorcyclic
acid lactones) had additive effects with
17p-estradiol in the presence of the con-
centration giving submaximal stimulation,
and none ofthe phytoestrogens we studied
(at concentrations below 1 PM) reduced
the proliferation rate ofbreast cancer cells,
i.e., had antiestrogenic effects in the pres-
ence of17p-estradiol (22).
In addition to the interaction with ER,
dietary estrogens or structurally related
compounds might compete with endoge-
nous estrogens for the active site of the
estrogen-biosynthesizing and estrogen-
metabolizing enzymes and thus reduce the
concentration of biologically active
endogenous estrogens. Coumestrol and
genistein have been shown to inhibit the
reduction of estrone to 170-estradiol by
estrogen-specific 17p-hydroxysteroid oxi-
doreductase type 1 (EC 1.1.1.62, also
known as 17,B-hydroxysteroid dehydroge-
nase type 1, 17P-HSD type 1) (24). This
enzyme is expressed in steroidogenic cells
such as ovarian granulosa cells and placen-
tal trophoblasts, as well as in some target
tissues of estrogen action, such as normal
and malignant breast and endometrium.
The antibody against estrogen-specific 17p-
hydroxysteroid oxidoreductase stains the
urethral epithelium in the mouse (25) as
well as in man (26). The immunostaining
of epithelium extends to the periurethral
parts of the dorsolateral lobes, coagulating
glands, and seminal vesicles in the mouse.
These are also the sites where metaplastic
epithelium and most dysplastic lesions are
found. Changes in the 17p-oxidoreduction
status of endogenous estrogens (estradiol
and estrone) may considerably modify the
biological activities of these hormones.
This would have biological significance if
continuous estrogen stimulation were
needed for the development of dysplasia.
At present, there is no direct evidence to
support this hypothesis.
Moreover, the possibility remains that
the chemopreventive action of soy is not
due to the antiestrogenicity of soy-derived
phytoestrogens. At very high concentra-
tions, phytoestrogens are reported to have
effects not related to estrogen action.
Genistein, an isoflavonoid phytoestrogen,
is a potent inhibitor of both estrogen
receptor negative and positive breast cancer
cells (27) and of tyrosine protein kinase
activity of several growth factor receptors
and oncogenes that may be associated with
tumor cell growth (28). Further, the inhi-
bition of DNA topoisomerase II has been
suggested as an alternative mechanism for
the action ofisoflavones (29). Genistein is
also an inhibitor of angiogenesis, which
may partly explain the possible antitumor
activity of phytoestrogens (30). The rele-
vance of these mechanisms for understand-
ing the possible antiestrogenic action ofsoy
or soy-derived estrogens in the male mouse
is not known. It is noteworthy that soy had
no general inhibitory effect on prostatic
growth in neonatally untreated animals (7).
In addition to phytoestrogens, soybeans
contain several other potential anticarcino-
genic agents such as protease inhibitors,
phytosterols, saponins, and inositol hexa-
phosphate (1,31); their possible roles as
chemopreventive agents cannot be excluded
in the present model.
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